Search research articles
Contact Us
Filters
Showing results (171-180 of 197) with videos related to
Page
of 20
Sort By:
Gut
|
April 25, 2020
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis
Marina Barcena-Varela, Hannah Paish, Laura Alvarez, et al.
Hepatology (Baltimore, Md.)
|
May 31, 2017
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma
Ander Arbelaiz, Mikel Azkargorta, Marcin Krawczyk, et al.
Nature Genetics
|
July 20, 2010
Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis
Gideon M Hirschfield, Xiangdong Liu, Younghun Han, et al.
Annals of Hepatology
|
August 15, 2024
Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma
Louisa Stern, Constantin Schmidt, Lorenz Kocheise, et al.
Gut
|
January 30, 2020
TGF-β2 silencing to target biliary-derived liver diseases
Anne Dropmann, Steven Dooley, Bedair Dewidar, et al.
BMC Medical Genomics
|
January 7, 2017
A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients
Agnieszka Paziewska, Andrzej Habior, Agnieszka Rogowska, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 3, 2020
Synergistic effects of extracellular vesicle phenotyping and AFP in hepatobiliary cancer differentiation
Sabine K Urban, Hanna Sänger, Marcin Krawczyk, et al.
Gastroenterology
|
April 5, 2021
Epithelia-Sensory Neuron Cross Talk Underlies Cholestatic Itch Induced by Lysophosphatidylcholine
Yong Chen, Zi-Long Wang, Michele Yeo, et al.
JHEP Reports : Innovation in Hepatology
|
May 17, 2021
Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury
Paula Iruzubieta, Naroa Goikoetxea-Usandizaga, Lucía Barbier-Torres, et al.
Hepatology (Baltimore, Md.)
|
September 9, 2024
Efficacy and safety of infliximab in patients with autoimmune hepatitis
Cumali Efe, Ellina Lytvyak, Tuğçe Eşkazan, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 197) with videos related to
Sort By:
Page
of 20
Gut
|
April 25, 2020
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis
Marina Barcena-Varela, Hannah Paish, Laura Alvarez, et al.
Hepatology (Baltimore, Md.)
|
May 31, 2017
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma
Ander Arbelaiz, Mikel Azkargorta, Marcin Krawczyk, et al.
Nature Genetics
|
July 20, 2010
Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis
Gideon M Hirschfield, Xiangdong Liu, Younghun Han, et al.
Annals of Hepatology
|
August 15, 2024
Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma
Louisa Stern, Constantin Schmidt, Lorenz Kocheise, et al.
Gut
|
January 30, 2020
TGF-β2 silencing to target biliary-derived liver diseases
Anne Dropmann, Steven Dooley, Bedair Dewidar, et al.
BMC Medical Genomics
|
January 7, 2017
A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients
Agnieszka Paziewska, Andrzej Habior, Agnieszka Rogowska, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 3, 2020
Synergistic effects of extracellular vesicle phenotyping and AFP in hepatobiliary cancer differentiation
Sabine K Urban, Hanna Sänger, Marcin Krawczyk, et al.
Gastroenterology
|
April 5, 2021
Epithelia-Sensory Neuron Cross Talk Underlies Cholestatic Itch Induced by Lysophosphatidylcholine
Yong Chen, Zi-Long Wang, Michele Yeo, et al.
JHEP Reports : Innovation in Hepatology
|
May 17, 2021
Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury
Paula Iruzubieta, Naroa Goikoetxea-Usandizaga, Lucía Barbier-Torres, et al.
Hepatology (Baltimore, Md.)
|
September 9, 2024
Efficacy and safety of infliximab in patients with autoimmune hepatitis
Cumali Efe, Ellina Lytvyak, Tuğçe Eşkazan, et al.
Page
of 20